ANNOUNCEMENT
New Member – Dr. Shigeki Ishikawa
April 3, 2024
Introducing new member of Bio2Q
We are delighted to welcome Dr. Shigeki Ishikawa as our Principal Investigator at Q core of Bio2Q.
The greeting from Dr. Ishikawa is as follows:
“I started working as a Bio2Q Advisor at the end of November 2023, and in April 2024 I started working as a P.I. of Bio2Q project professor of the Q-core team.
I worked for IBM’s Research & Development until 2020, as an executive management of new business creation utilizing leading edge new technologies, such as AI, Quantum computing, formulating new strategies, promoting new technology, and providing educational support. Combination of new IT and domains such medicine, healthcare , is quite an exciting new area for human lives, then I focused on this for 10 years there.
Since 2021, I have been appointed as a specially appointed professor at the AI Consortium at Keio University, Faculty of Science and Engineering, where I have worked with students to launch AI education and provide guidance on basic education and projects that utilize AI.
At Bio2Q, I will mainly contribute to the development of strategy & roadmap of Quantum Computing & AI in Bio-1・Bio-2 for accelerating biology research. Those technologies will make it possible to improve research quality and speed further more. At first, we are focusing on generative AI for Bio-1 ・Bio2 research.
I am very excited about this new challenge. I am looking forward to working with you to make Bio2Q much more exciting.”
More Bio2Q News
The 3rd Keio University WPI-Bio2Q International Symposium
The Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold the 3rd Keio University WPI-Bio2Q International S...
[Publication] Advantages of Fixing Spins in Quantum Annealing
Title Advantages of Fixing Spins in Quantum Annealing Authors Tomohiro Hattori [1]; Hirotaka Irie [2]; Tadashi Kadowaki [2],[3]; and ...
[Publication] Characterization of UGT8 as a monogalactosyl diacylglycerol syntha...
Title Characterization of UGT8 as a monogalactosyl diacylglycerol synthase in mammals Authors Yohsuke Ohba [1],[2]; Mizuki Motohashi...
Five WPI-Bio2Q Researchers Named as “Highly Cited Researchers 2024”
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) is proud to announce that five of our researchers were selected...
[Publication] The impact of retrotransposons on zygotic genome activation and th...
Title The impact of retrotransposons on zygotic genome activation and the chromatin landscape of early embryos Authors Therese Solber...